# Prediabetes Associates With Musculoskeletal Alterations Independent of Total Body Adiposity

**Authors:** Alan Fappi, Clifton J. Holmes, Chao Cao, Vasavi Shabrish, Aman P. Aher, Karen Shen, Paul K. Commean, Dwight A. Towler, Dominic N. Reeds, Gretchen A. Meyer, Bettina Mittendorfer

PMC · DOI: 10.1002/jcsm.70198 · 2026-01-29

## TL;DR

Prediabetes is linked to changes in muscles and bones, even when body fat levels are the same.

## Contribution

Shows metabolic issues in prediabetes affect musculoskeletal health beyond body fat.

## Key findings

- Prediabetic individuals had lower muscle mass and bone density compared to controls.
- Muscle fibers were smaller and macrophages fewer in prediabetic participants.
- Intramyocellular lipid content was significantly higher in the prediabetic group.

## Abstract

Excess adiposity is a major risk factor for insulin resistance, prediabetes, and Type 2 diabetes and increases the risk for sarcopenia and osteosarcopenia later in life. It has been proposed that altered metabolic function and musculoskeletal status in people with obesity are directly linked, presumably because they share common pathophysiological mechanisms. However, the effect of metabolic dysfunction, independent of adiposity, on musculoskeletal status is unknown.

We performed a comprehensive assessment of musculoskeletal status in people with overweight/obesity and prediabetes (n = 12; 72% women; age: 67 ± 6 years; weight: 81 ± 11 kg; mean ± SD) and a control group of sex‐, age‐ and adiposity‐matched participants with normoglycaemia (n = 18; 67% women; age: 65 ± 6 years; weight: 81 ± 12 kg).

Appendicular muscle mass expressed relative to the sarcopenia threshold (−5.6% ± 2.5% vs. 1.8% ± 2.0%; mean ± SEM) and the bone mineral density T‐score (−0.22 ± 0.41 vs. 0.82 ± 0.33) were lower (p < 0.05) in the prediabetic group than the control group. Additionally, the prediabetic group had ~25% smaller (by cross‐sectional area) myofibres and ~40% fewer muscle Type 2 macrophages (all p < 0.05), whereas intramyocellular lipid content was more than 50% higher (p < 0.05) in the prediabetic than the control group. Maximal muscle strength was not different between the two groups, but muscle strength during repeated maximum voluntary contractions declined more (p < 0.05) in the prediabetic group.

In people with overweight/obesity, metabolic dysfunction associates with musculoskeletal dysfunction independent of adiposity.

## Linked entities

- **Diseases:** prediabetes (MONDO:0006920), Type 2 diabetes (MONDO:0005148)

## Full-text entities

- **Genes:** FST (follistatin) [NCBI Gene 10468] {aka FS}, MYOD1 (myogenic differentiation 1) [NCBI Gene 4654] {aka CMYO17, CMYP17, MYF3, MYOD, MYODRIF, PUM}, PKM (pyruvate kinase M1/2) [NCBI Gene 5315] {aka CTHBP, HEL-S-30, OIP3, PK3, PKM2, TCB}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, ATG7 (autophagy related 7) [NCBI Gene 10533] {aka APG7-LIKE, APG7L, GSA7, SCAR31}, MYOG (myogenin) [NCBI Gene 4656] {aka MYF4, bHLHc3, myf-4}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, MSTN (myostatin) [NCBI Gene 2660] {aka GDF8, MSLHP}, PFKM (phosphofructokinase, muscle) [NCBI Gene 5213] {aka ATP-PFK, GSD7, PFK-1, PFK-A, PFK1, PFKA}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, MRC1 (mannose receptor C-type 1) [NCBI Gene 4360] {aka CD206, CLEC13D, CLEC13DL, MMR, MRC1L1, bA541I19.1}, SMAD3 (SMAD family member 3) [NCBI Gene 4088] {aka HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, BECN1 (beclin 1) [NCBI Gene 8678] {aka ATG6, VPS30, beclin1}, IL6R (interleukin 6 receptor) [NCBI Gene 3570] {aka CD126, HIES5, IL-1Ra, IL-6R, IL-6R-1, IL-6RA}, BGLAP (bone gamma-carboxyglutamate protein) [NCBI Gene 632] {aka BGP, OC, OCN}, FOXO3 (forkhead box O3) [NCBI Gene 2309] {aka AF6q21, FKHRL1, FKHRL1P2, FOXO2, FOXO3A}, IRS1 (insulin receptor substrate 1) [NCBI Gene 3667] {aka HIRS-1}, IRS2 (insulin receptor substrate 2) [NCBI Gene 8660] {aka IRS-2}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, CST3 (cystatin C) [NCBI Gene 1471] {aka ADLDWA, ARMD11, HEL-S-2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** Sarcopenia (MESH:D055948), Musculoskeletal (MESH:D009140), Obesity (MESH:D009765), impaired beta-cell function (MESH:D007340), mobility disability (MESH:D014086), mitochondrial dysfunction (MESH:D028361), impaired fasting glucose (MESH:D007003), Osteoporosis (MESH:D010024), muscle fatigability (MESH:D009759), Osteopenia (MESH:D001851), Type 2 diabetes (MESH:D003924), Muscle fatigue (MESH:D005221), pre (MESH:D058246), fibrosis (MESH:D005355), organ system dysfunction (MESH:D009102), falls (MESH:C537863), overweight (MESH:D050177), Prediabetes (MESH:D011236), musculoskeletal alterations (MESH:D009139), Diabetes (MESH:D003920), muscle (MESH:D019042), Insulin resistance (MESH:D007333), impaired glucose tolerance (MESH:D018149), COVID-19 (MESH:D000086382), muscle weakness (MESH:D018908), loss of independence (MESH:D064129), bone fractures (MESH:D050723), inflammation (MESH:D007249), metabolic dysfunction (MESH:D008659), collagen (MESH:D003095), Adiposity (MESH:D018205)
- **Chemicals:** cortisol (MESH:D006854), pyruvate (MESH:D019289), glucose (MESH:D005947), DAPI (MESH:C007293), nitrogen (MESH:D009584), ADP (MESH:D000244), glutamate (MESH:D018698), TRIzol (MESH:C411644), lipid (MESH:D008055), dehydroepiandrosterone sulphate (MESH:D019314), Choloroform (-), rotenone (MESH:D012402), succinate (MESH:D019802), Oxygen (MESH:D010100), phosphocreatine (MESH:D010725), acetone (MESH:D000096), malate (MESH:C030298), FCCP (MESH:D002259), alcohol (MESH:D000438), Oil Red O (MESH:C011049)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12856049/full.md

---
Source: https://tomesphere.com/paper/PMC12856049